Translational Radiobiology,
Department of Radiation Oncology,
Uniklinikum Erlangen,
Translational Radiobiology, Department of Radiation Oncology, Uniklinikum Erlangen
Anna-Jasmina Donaubauer has not added Biography.
If you are Anna-Jasmina Donaubauer and would like to personalize this page please email our Author Liaison for assistance.
One-Tube Multicolor Flow Cytometry Assay (OTMA) for Comprehensive Immunophenotyping of Peripheral Blood.
Methods in molecular biology (Clifton, N.J.) , 2019 | Pubmed ID: 30539471
Analysis of the immune status from peripheral whole blood with a single-tube multicolor flow cytometry assay.
Methods in enzymology , 2020 | Pubmed ID: 32000906
Low Dose Radiation Therapy, Particularly with 0.5 Gy, Improves Pain in Degenerative Joint Disease of the Fingers: Results of a Retrospective Analysis.
International journal of molecular sciences Aug, 2020 | Pubmed ID: 32824064
The Influence of Radiation on Bone and Bone Cells-Differential Effects on Osteoclasts and Osteoblasts.
International journal of molecular sciences Sep, 2020 | Pubmed ID: 32887421
Low- vs. high-dose radiotherapy in Graves' ophthalmopathy: a retrospective comparison of long-term results.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] Oct, 2021 | Pubmed ID: 33860819
Chromosome Aberrations in Lymphocytes of Patients Undergoing Radon Spa Therapy: An Explorative mFISH Study.
International journal of environmental research and public health Oct, 2021 | Pubmed ID: 34682498
Low Dose Radiation Therapy Induces Long-Lasting Reduction of Pain and Immune Modulations in the Peripheral Blood - Interim Analysis of the IMMO-LDRT01 Trial.
Frontiers in immunology , 2021 | Pubmed ID: 34712229
Low-Dose Radiotherapy Leads to a Systemic Anti-Inflammatory Shift in the Pre-Clinical K/BxN Serum Transfer Model and Reduces Osteoarthritic Pain in Patients.
Frontiers in immunology , 2021 | Pubmed ID: 35046940
Induction chemoimmunotherapy followed by CD8+ immune cell-based patient selection for chemotherapy-free radioimmunotherapy in locally advanced head and neck cancer.
Journal for immunotherapy of cancer Jan, 2022 | Pubmed ID: 35078923
Corrigendum: Low Dose Radiation Therapy Induces Long-Lasting Reduction of Pain and Immune Modulations in the Peripheral Blood - Interim Analysis of the IMMO-LDRT01 Trial.
Frontiers in immunology , 2022 | Pubmed ID: 35197987
Anti-inflammatory effects of an autologous gold-based serum therapy in osteoarthritis patients.
Scientific reports Mar, 2022 | Pubmed ID: 35241691
Modulation of Differentiation and Bone Resorbing Activity of Human (Pre-) Osteoclasts After X-Ray Exposure.
Frontiers in immunology , 2022 | Pubmed ID: 35603191
Low-dose radiotherapy of osteoarthritis: from biological findings to clinical effects-challenges for future studies.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] Dec, 2023 | Pubmed ID: 36602569
Prospective Evaluation of CD45RA+/CCR7- Effector Memory T (T) Cell Subsets in Patients with Primary and Secondary Brain Tumors during Radiotherapy of the Brain within the Scope of the Prospective Glio-CMV-01 Clinical Trial.
Cells Feb, 2023 | Pubmed ID: 36831183
Machine Learning-assisted immunophenotyping of peripheral blood identifies innate immune cells as best predictor of response to induction chemo-immunotherapy in head and neck squamous cell carcinoma - knowledge obtained from the CheckRad-CD8 trial.
Neoplasia (New York, N.Y.) Mar, 2024 | Pubmed ID: 38232493
Osteo-immunological impact of radon spa treatment: due to radon or spa alone? Results from the prospective, thermal bath placebo-controlled RAD-ON02 trial.
Frontiers in immunology , 2023 | Pubmed ID: 38292488
Effects of serial radon spa therapy on pain and peripheral immune status in patients suffering from musculoskeletal disorders- results from a prospective, randomized, placebo-controlled trial.
Frontiers in immunology , 2024 | Pubmed ID: 38380316
Defining intra-tumoral and systemic immune biomarkers for locally advanced head-and-neck cancer - detailed protocol of a prospective, observatory multicenter trial (ImmunBioKHT) and first results of the immunophenotyping of the patients' peripheral blood.
Frontiers in oncology , 2024 | Pubmed ID: 39346733
Flow cytometry-based monitoring of myeloid-derived suppressor cells in the peripheral blood of patients with solid tumors.
Methods in cell biology , 2025 | Pubmed ID: 39824553
Anna-Jasmina Donaubauer1,2,3,
Anna Schäfer1,
Simon Hundsdorfer1,
Rainer Fietkau2,4,
Udo S. Gaipl1,2,
Tina Jost1,2
1Translational Radiobiology, Department of Radiation Oncology, Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg,
2, Comprehensive Cancer Center Erlangen-EMN,
3, Bayerischerisches Zentrum für Krebsforschung,
4Department of Radiation Oncology, Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg
Copyright © 2025 MyJoVE Corporation. All rights reserved